Literature DB >> 26469731

[A new perspective on measuring quality of life using the capability approach].

Marc van Hoof1, Steven F G Jeuring, Robert J Stokroos, Manuela A Joore.   

Abstract

Healthcare evaluations are used for optimal allocation of healthcare budgets. Most studies assess the effects of care in terms of Quality-Adjusted Life Years (QALY): the product of survival and quality of life per life year. Currently, quality of life is determined by questionnaires that measure mostly in terms of what a person actually 'does' or 'is' (functioning). This approach has some practical and ethical limitations which affect how we value our healthcare system. In the past decades, an alternative movement called the capability approach has attracted considerable interest. This philosophy advocates enabling people in terms of capabilities: that is, the extent to which a person is able or willing to function. This ensures that people have the freedom to achieve without a particular belief as to what constitutes a good life being imposed upon them. The ICEpop CAPability measure for Adults (ICECAP) questionnaire was developed in the United Kingdom by Coast et al. to evaluate quality of life based on this approach. Dutch translations of ICECAP-A (for adults) and ICECAP-O (for the elderly) are available and may prove to be especially beneficial in fields where treatment effects are not confined to health gains.

Entities:  

Mesh:

Year:  2015        PMID: 26469731

Source DB:  PubMed          Journal:  Ned Tijdschr Geneeskd        ISSN: 0028-2162


  2 in total

1.  Estimating loss in capability wellbeing in the first year of the COVID-19 pandemic: a cross-sectional study of the general adult population in the UK, Australia and the Netherlands.

Authors:  Paul Mark Mitchell; Rachael L Morton; Mickaël Hiligsmann; Samantha Husbands; Joanna Coast
Journal:  Eur J Health Econ       Date:  2022-07-24

2.  Minimally Invasive Ponto Surgery compared to the linear incision technique without soft tissue reduction for bone conduction hearing implants: study protocol for a randomized controlled trial.

Authors:  Tim G A Calon; Marc van Hoof; Herbert van den Berge; Arthur J G de Bruijn; Joost van Tongeren; Janny R Hof; Jan Wouter Brunings; Sofia Jonhede; Lucien J C Anteunis; Miranda Janssen; Manuela A Joore; Marcus Holmberg; Martin L Johansson; Robert J Stokroos
Journal:  Trials       Date:  2016-11-09       Impact factor: 2.279

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.